What are the 4 Stages for PSP?

What are the 4 Stages for PSP?

It has been said there are four stages, but because there is so little research they are a guideline only.

Many people experience some stage four symptoms at stage one or overlap stages. Some never experience certain symptoms and then others can experience ones not listed. The impact it has on each individual varies dramatically.

 

Progressive Supranuclear Palsy (PSP) is a rare neurodegenerative disorder that affects movement, balance, vision, speech, and cognitive function. The disease progresses slowly over time, and its symptoms typically become more severe as the disease advances. While not everyone with PSP experiences the same symptoms or progression, there are generally four recognized stages of PSP:

  1. Early stage: In the early stage of PSP, individuals may experience symptoms such as difficulty with balance and coordination, changes in gait, and problems with eye movement. These symptoms may be subtle and easily dismissed as normal aging or a different condition.

  2. Mid-stage: In the mid-stage of PSP, symptoms become more pronounced and can include falls, speech and swallowing difficulties, and cognitive impairment such as problems with memory and executive function. Depression and apathy are also common.

  3. Advanced stage: In the advanced stage of PSP, individuals may become wheelchair-bound and require assistance with daily activities such as eating, dressing, and bathing. Symptoms such as rigidity, spasticity, and involuntary movements become more severe.

  4. End-of-life stage: In the end-of-life stage of PSP, individuals may be bedridden and require around-the-clock care. They may have difficulty swallowing, become more susceptible to infections, and experience other complications related to the progression of the disease.

It's important to note that not everyone with PSP will experience all of these stages, and the progression of the disease can vary widely from person to person. Additionally, some individuals may experience rapid progression, while others may experience a slower course of the disease.

 

Here is the four stages below in more detail;

 

Early stage:
May present via the fracture clinic, falls services, eye specialist or speech and language therapist. The early stage typically spans years 0-1.

> Ambulant.
> Occasional falls.
> Unsteadiness and poor balance.
> Possible visual problems affecting ability to read.
> Voice changes, for example reduced volume.
> Mood changes.
> Reduced socializing.
> Changes in mood and behavior, including apathy and anxiety.

Mid stage:
Many people reach this stage before diagnosis. Consider discussing advance care planning and advance decisions to refuse treatment. Consider referral to palliative care services. The mid stage typically spans years 2-3.

> Ambulant with aids.
> High risk of falls and injury.
> Visual problems affecting self-care abilities, for example eating and walking as unable to move eyes to see.
> Speech increasingly unintelligible.
> Inability to initiate conversation.
> Impulsivity (risky or impulsive behavior).
> Apathy.
> Dysphagia.
> High level of supervision required.
> Increasingly socially withdrawn.

Advanced stage:
Patients should be on GP palliative care register and have access to specialist palliative care.
The advanced stage typically spans years 3-6.

> Mobility significantly compromised, probably chair bound requiring a wheelchair for mobility.
> Significant visual problems.
> Significant muscle stiffness.
> Significant communication problems, but probably still able to understand.
> High risk of aspiration and pneumonia as a result of dysphagia.
> Pain.
> Increasing periods of sleepiness.
> Incontinence.
> Severely withdrawn socially.
> Dependent for most or all aspects of care.

End of life stage:
This stage is difficult to detect, but may be indicated by reduced levels of consciousness, inability to eat or drink, acute infection, a fall or major fracture, and rapid and significant weight loss. The end of life stage typically spans 6-8 weeks.

> Severe impairments and disabilities.
> Rapid and marked deterioration in condition.
> Decisions with regard to treatment interventions may be required, considering an individual’s previously expressed wishes (advance decisions to refuse treatment).

Discover the Benefits of Vielight Red Light Therapy for Atypical Parkinsonism

 

Back to blog

131 comments

I have psp and I don’t like one bit. I came to this website to find out about my eyes . I think I should be happy to be here. This is a terrible disease and I would not wish it on my worst enemy

Carla Krahl

My mother died at age 84 from the effects of PSP. Like others, for several years the doctor treated her for Parkinson’s and COPD. She had no tremors, but had falls, masked face, couldn’t walk, etc. At the end, she was still very aware, but could not speak, could not blink, and breathing was difficult. She lost the ability to feed herself, as well. She choked on everything including sips on f water. It was very hard to see a strong, independent woman just being locked inside her own body. God finally took her home in October of 2015.

Jeanne Pratt

My husband had PSP. When he had difficulty swallowing, his doctor perscribed Donepezil 10 mg. This medication was like a light turning on for his brain and his swallowing improved for several years. When his swallowing became worse, I read a PSP article on the NIH website stating that patients responded well to up to 20 mg of Donepezil. After bringing this to his doctors attention, she increased his dosage to 20 mg. Again, my husband responded like there was a light turning on in his brain and his speech therapist was amazed at the improvement in his swallowing.

PSMC

It took us 4 years to get my husband diagnosed. He saw 5 Neurologist. Right now I am not ready to talk about it. He is still alive but I don’t know for how long.

Carol

My husband is in a rehab right now. He fell out of bed a week ago, broke his collarbone, cut his head, so devastating for both of us. He has PSP, diagnosed in February 2023.
Was treated for Parkinson’s for three years, finally we found the neurologist who took some time with my husband.
He is no longer walking, I am his caregiver with part time aide help. Short term memory gone, not talking much, but still getting speech therapy, PT and OT. These therapies help.
Hang in there. Our loved one is worth all the time and effort we put in.
My dear husband is 79 and I am 78. Hoping to get him out of rehab soon, and home with me! Thank you for listening.

Maxine Wernik-Fausak

Leave a public comment:

Please note, comments need to be approved before they are published.

  • 🥯 Bagel Fundraiser

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

    🥯 Bagel Fundraiser

    JOIN THE COLEEN CUNNINGHAM FOUNDATION 🥯 Bagel Fundraiser FOR THE BENEFIT OF THOSE WITHAtypical Parkinson Diseases NOVEMBER 2ND • 11-1 PM AT THE ROCKVILLE JCC IN PARTNERSHIP WITH BETHESDA BAGELS

  • HOPE by Bhavna

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

    HOPE by Bhavna

    Remember the first timerobins sang in your garden,their delicate bodies pulsing with song,their hearts daring to rise, like yours.How the moon spilled its silver over your window,and your mother said,...

  • Active Neurodegenerative Disease Clinical Trials (PSP, MSA, DLB, CBS, Parkinsonian Syndromes)

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment

    Active Neurodegenerative Disease Clinical Trial...

    Progressive Supranuclear Palsy (PSP) Trials ClinicalTrials.gov ID: NCT06355531 – PROSPERPurpose: To evaluate whether FNP-223 slows disease progression in PSP, using the PSP Rating Scale (PSPRS) over 52 weeks. The trial also...

    1 comment
  • Recruiting participants for a groundbreaking study: “Assessing Cognitive Trajectories in Progressive Supranuclear Palsy Using Remote Computerized Reaction Time Tasks.”

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

    Recruiting participants for a groundbreaking st...

    Melbourne, Victoria – September 9, 2025 – The CCF Coleen Cunningham Foundation is partnering with researchers at the Alfred Hospital and Monash University to recruit participants for a groundbreaking study:...

1 of 4